Position in RVMD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$10,016,750
New position
Shares Held
103,000
first reported quarter
Ownership
0.048%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ING GROEP NV holds $89,261,587 across 9 Biotechnology names. RVMD ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,425 | $29,214,879 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
31,191 | $24,099,414 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
391,500 | $10,844,550 | |
| 4 | RVMD |
Revolution Medicines, Inc.
This page
|
103,000 | $10,016,750 | |
| 5 | NKTR |
Nektar Therapeutics
|
100,000 | $7,195,000 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
28,214 | $5,333,856 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
122,100 | $1,150,182 | |
| 8 | INSM |
INSMED Inc
|
5,996 | $980,465 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,016,750 | 103,000 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||